CYP2C19 and esophageal squamous cell carcinoma: This finding is inconsistent with a recent report from Shi et al. [27], who found that the frequency of the CYP2C19*3 A allele was significantly higher in ESCC patients than in controls (5.57% vs 1.86%, P = 0.004).